Advertisement
U.S. markets close in 9 minutes
Advertisement

Baxter International Inc. (BAX)

NYSE - Nasdaq Real Time Price. Currency in USD
Visitors trend2W10W9M
35.96+0.16 (+0.45%)
As of 03:51PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Fast Stochastic

Fast Stochastic

Performance Outlook
Previous Close35.80
Open35.85
Bid35.99 x 900
Ask36.01 x 1200
Day's Range35.62 - 36.12
52 Week Range31.01 - 53.80
Volume2,024,373
Avg. Volume5,083,563
Market Cap18.243B
Beta (5Y Monthly)0.61
PE Ratio (TTM)78.17
EPS (TTM)0.46
Earnings DateFeb 07, 2024 - Feb 12, 2024
Forward Dividend & Yield1.16 (3.24%)
Ex-Dividend DateNov 30, 2023
1y Target Est42.77
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for BAX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Baxter International Inc.
    Mid Cap U.S. Pick List November 2023This pick list highlights constituents of the Morningstar US Mid Cap Index that we believe offer investors the best risk-adjusted return prospects. The market capitalization range for U.S. mid-caps typically falls between $1 billion and $8 billion and represents 20% of the total capitalization of the U.S. equity market.
    Rating
    Fair Value
    Economic Moat
    27 days agoMorningstar
View more
  • GlobeNewswire

    Spectral Medical Provides November Tigris Trial Update

    79 patients enrolled TORONTO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update for the month of November on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock. 79 patients enrolled to date an

  • Business Wire

    The Baxter International Foundation and UNICEF Partner to Expand Access to Safe Water and Sanitation in Egypt

    DEERFIELD, Ill. & NEW YORK, November 28, 2023--The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), and UNICEF, today announced a partnership to improve access to safe drinking water and sanitation in five water-challenged regions in Egypt. Supported by a $2.5 million grant from the Foundation, this three-year initiative aims to implement climate-smart water, sanitation and hygiene (WASH) programming for thousands of people in Upper Egypt’s governor

  • Simply Wall St.

    Here's Why We're Wary Of Buying Baxter International's (NYSE:BAX) For Its Upcoming Dividend

    It looks like Baxter International Inc. ( NYSE:BAX ) is about to go ex-dividend in the next 3 days. Typically, the...